Question for everyone: if there is the possibility of partnering with Merck. Wouldn’t you think they see the potential with Leronlimab and that they, as a company would be using their resources to help get the hold lifted? This would allow them to move forward with some new potential revenue streams. Merck is a powerhouse BP correct?
Thoughts anyone?